VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy
PLOS Biology · 03.02.2025 · 23 (2) · e3002961
DOI: 10.1371/journal.pbio.3002961 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 03.02.2025. Verfasst von Huaji Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Inflammasomes, Inflammatory Bowel Diseases, Autophagy, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Guangzhou Science and Technology Research Program.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic and potentially life-threatening inflammatory disease of gastroenteric tissue characterized by episodes of intestinal inflammation, but the underlying mechanisms remain elusive. Here, we explore the role and precise mechanism of Van-Gogh-like 2 (VANGL2) during the pathogenesis of IBD. VANGL2 decreases in IBD patients and dextran sulfate sodium (DSS)-induced colitis in mice. Myeloid VANGL2 deficiency exacerbates the progression of DSS-induced colitis in mice and specifically enhances the activation of NLRP3 inflammasome in macrophages. NLRP3-specific inhibitor MCC950 effectively alleviates DSS-induced colitis in VANGL2 deficient mice. Mechanistically, VANGL2 interacts with NLRP3 and promotes the autophagic degradation of NLRP3 through enhancing the K27-linked polyubiquitination at lysine 823 of NLRP3 by recruiting E3 ligase MARCH8, leading to optineurin (OPTN)-mediated selective autophagy. Notably, decreased VANGL2 in the peripheral blood mononuclear cells from IBD patients results in overt NLRP3 inflammasome activation and sustained inflammation. Taken together, this study demonstrates that VANGL2 acts as a repressor of IBD progression by inhibiting NLRP3 inflammasome activation and provides insights into the crosstalk between inflammation and autophagy in preventing IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Orthopaedics, Yue Bei People's Hospital Affiliated to Shantou University Medical College, Shaoguan, Guangdong, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Joint Surgery, the Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Xiao Yu
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Guangzhou Science and Technology Research Program
- China Postdoctoral Science Foundation
- Foundation for the President of Nanfang Hospital of Southern Medical University
Zitieren
APA
Jiang, H., Xie, Y., Hu, Z., Lu, J., Zhang, J., Li, H., Zeng, K., Peng, W., Yang, C., Huang, J., Han, Z., Bai, X., & Yu, X. (2025). VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy. PLOS Biology, 23(2), e3002961. https://doi.org/10.1371/journal.pbio.3002961
Vancouver
Jiang H, Xie Y, Hu Z, Lu J, Zhang J, Li H, et al. VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy. PLOS Biology. 2025;23(2):e3002961. doi:10.1371/journal.pbio.3002961
BibTeX
@article{Jiang2025,
author = {Jiang, Huaji and Xie, Yingchao and Hu, Zhiqiang and Lu, Jiansen and Zhang, Jiahuan and Li, Hongyu and Zeng, Ke and Peng, Wenqiang and Yang, Cheng and Huang, Junsheng and Han, Zelong and Bai, Xiaochun and Yu, Xiao},
title = {VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {2},
pages = {e3002961},
doi = {10.1371/journal.pbio.3002961}
}
EUVIMED